Conditions: Ovarian Neoplasms
Allocation:  | Intervention model: PARALLEL
Enrollment: 89
Healthy volunteers: no

Brief summary:
The primary objective of this study is to estimate the Progression Free Survival Rates (PFS) of patients with relapsed ovarian cancer after 9 months of continuous treatment with either BIBF 1120 or matching placebo.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: BIBF1120 intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: